0001104659-23-005480.txt : 20230120
0001104659-23-005480.hdr.sgml : 20230120
20230120174204
ACCESSION NUMBER: 0001104659-23-005480
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230118
FILED AS OF DATE: 20230120
DATE AS OF CHANGE: 20230120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hagopian Henry III
CENTRAL INDEX KEY: 0001821822
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39202
FILM NUMBER: 23542078
MAIL ADDRESS:
STREET 1: C/O ORGANOGENESIS INC., 85 DAN ROAD
CITY: CANTON
STATE: MA
ZIP: 02021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Annovis Bio, Inc.
CENTRAL INDEX KEY: 0001477845
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262540421
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1055 WESTLAKES DRIVE, SUITE 300
CITY: BERWYN
STATE: PA
ZIP: 19312
BUSINESS PHONE: 610-727-3913
MAIL ADDRESS:
STREET 1: 1055 WESTLAKES DRIVE, SUITE 300
CITY: BERWYN
STATE: PA
ZIP: 19312
FORMER COMPANY:
FORMER CONFORMED NAME: QR Pharma, Inc.
DATE OF NAME CHANGE: 20091202
4
1
tm234043-5_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2023-01-18
0
0001477845
Annovis Bio, Inc.
ANVS
0001821822
Hagopian Henry III
C/O ANNOVIS BIO, INC.
1055 WESTLAKES DRIVE, SUITE 300
BERWYN
PA
19312
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
13.17
2023-01-18
4
A
0
7672
0
A
2033-01-18
Common Stock
7672
7672
D
The stock option shall vest in eight consecutive quarterly installments of 1,918 shares each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025.
/s/ Henry Hagopian III
2023-01-20